Skip to content
The Policy VaultThe Policy Vault

Teriparatide productsMedical Mutual

Chronic hypoparathyroidism, Natpara naive

Initial criteria

  • Natpara is not available
  • AND not well controlled on calcium supplements and active vitamin D alone
  • AND 25-hydroxyvitamin D stores sufficient
  • AND serum calcium >7.5 mg/dL before initiation
  • AND creatinine clearance >30 mL/min (two measurements) OR >60 mL/min AND serum creatinine <1.5 mg/dL
  • AND age ≥18 years
  • AND history of hypoparathyroidism >18 months
  • AND prescribed by or in consultation with an endocrinologist
  • AND no history of Paget’s disease or unexplained alkaline phosphatase elevation
  • AND no open epiphyses
  • AND no hereditary disorders predisposing to osteosarcoma
  • AND no prior skeletal radiation therapy

Reauthorization criteria

  • Reauthorization up to maximum 2 years lifetime use allowed if criteria remain satisfied

Approval duration

1 year (initial); 1 year (reauth); max 2 years total